117 related articles for article (PubMed ID: 3842256)
1. Comparison of the influence of nitrates, molsidomine and SIN-1, a molsidomine metabolite in acute coronary insufficiency.
Degré S; Sobolski J; Berkenboom G; Abramowicz M; Vandermoten P; Stoupel E
Bibl Cardiol; 1985; (39):129-34. PubMed ID: 3842256
[No Abstract] [Full Text] [Related]
2. [Inhibition of platelet aggregation by endothelium-derived relaxing factor-like agents].
Gerzer R; Karrenbrock B; Drummer C; Heim JM
Med Klin (Munich); 1990 Feb; 85 Suppl 1():18-22. PubMed ID: 2185403
[TBL] [Abstract][Full Text] [Related]
3. [Significance of vasospasm in myocardial infarction (II)--pre- and post-infarction angina and hypersensitivity of the coronary artery to ergonovine].
Yamagishi M; Kodama K; Nanto S; Taniura K; Koretsune Y; Kuzuya T; Tada M; Inoue M
Kokyu To Junkan; 1982 Oct; 30(10):1057-65. PubMed ID: 7156520
[No Abstract] [Full Text] [Related]
4. The effects of molsidomine and its metabolite SIN-1 on coronary vessel tone, platelet aggregation, and eicosanoid formation in vitro--inhibition of 12-HPETE biosynthesis.
Darius H; Ahland B; Rücker W; Klaus W; Peskar BA; Schrör K
J Cardiovasc Pharmacol; 1984; 6(1):115-21. PubMed ID: 6199592
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism of the vasodilating effect and blood platelet- antiaggregating activity of molsidomine and SIN-1].
Kukovetz WR; Holzmann S
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):260-5. PubMed ID: 3031569
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of oral molsidomine and nifedipine on methylergometrine-induced coronary artery spasm.
Danchin N; Juillière Y; Anconina J; Perrin O; Selton-Suty C; Cherrier F
Am J Cardiol; 1991 Jun; 67(15):1208-11. PubMed ID: 2035442
[TBL] [Abstract][Full Text] [Related]
7. Nitroglycerin-resistant coronary spasm treated with intracoronary linsidomine chlorhydrate (SIN-1).
Drobinski G; Montalescot G
Eur Heart J; 1990 May; 11(5):472-5. PubMed ID: 2112998
[TBL] [Abstract][Full Text] [Related]
8. The new long-acting coronary artery dilator molsidomine and its metabolite SIN-1.
Sobolski J; Vandermoten P; Stoupel E; Berkenboom G; Degre S
Am Heart J; 1985 Mar; 109(3 Pt 2):700-3. PubMed ID: 3838407
[TBL] [Abstract][Full Text] [Related]
9. [Diameter changes of epicardial coronary arteries and coronary stenoses after intracoronary application of SIN 1, a molsidomine metabolite].
Schulz W; Wendt T; Scherer D; Kober G
Z Kardiol; 1983 Jul; 72(7):404-9. PubMed ID: 6613236
[TBL] [Abstract][Full Text] [Related]
10. [Molsidomine: importance in treatment of circulation disorders].
Kmieć M; Ochmański W
Przegl Lek; 1998; 55(10):532-6. PubMed ID: 10224868
[TBL] [Abstract][Full Text] [Related]
11. [Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration].
Hug J; Hasenfuss G; Wollschläger H; Just HJ; Bonzel T
Med Klin (Munich); 1994 Jul; 89 Suppl 2():34-7. PubMed ID: 7968899
[No Abstract] [Full Text] [Related]
12. [Nitrates as thrombocyte function inhibitors].
De Caterina R
Z Kardiol; 1994 Jul; 83(7):463-73. PubMed ID: 7941647
[TBL] [Abstract][Full Text] [Related]
13. Active and passive changes in coronary diameter after vasodilation with SIN-1, the active metabolite of molsidomine.
Schulz W; Kober G; Bernauer R; Kaltenbach M
Am Heart J; 1985 Mar; 109(3 Pt 2):694-9. PubMed ID: 3838406
[TBL] [Abstract][Full Text] [Related]
14. Postoperative coronary vasospasm.
Addonizio VP; Harken AH; Goldberg S
Cardiovasc Clin; 1983; 14(1):111-21. PubMed ID: 6413061
[No Abstract] [Full Text] [Related]
15. [The ergonovin test and drug therapy. Effect of Ca++ antagonists and nitrates during ergonovine provocation].
Bethge HD; Bachmann K
Fortschr Med; 1982 Oct; 100(37):1715-22. PubMed ID: 7173775
[No Abstract] [Full Text] [Related]
16. [Nitric oxide in therapy of angina pectoris: nitrates or molsidomine?].
Schächinger V; Zeiher AM
Internist (Berl); 1997 May; 38(5):438-47. PubMed ID: 9264980
[No Abstract] [Full Text] [Related]
17. SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.
Block HU; Förster W; Heinroth I
Arzneimittelforschung; 1982; 32(3):189-94. PubMed ID: 6896278
[TBL] [Abstract][Full Text] [Related]
18. Long-acting coronary vasodilatory action of the molsidomine metabolite Sin 1: a quantitative angiographic study.
Serruys PW; Deckers JW; Luijten HE; Reiber JH; Tijssen JG; Chadha D; Hugenholtz PG
Eur Heart J; 1987 Mar; 8(3):263-70. PubMed ID: 3582385
[TBL] [Abstract][Full Text] [Related]
19. The clinical syndrome of variant angina.
Conti CR; Feldman RL; Pepine CJ
Cardiovasc Clin; 1983; 14(1):59-69. PubMed ID: 6352029
[No Abstract] [Full Text] [Related]
20. [Pharmacological basis of therapy with molsidomine].
Bassenge E
Herz; 1982 Oct; 7(5):296-306. PubMed ID: 6897544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
